Invention Grant
- Patent Title: Methods and compositions to increase somatic cell nuclear transfer (SCNT) efficiency by removing histone H3-lysine trimethylation
-
Application No.: US16017157Application Date: 2018-06-25
-
Publication No.: US10266848B2Publication Date: 2019-04-23
- Inventor: Yi Zhang , Shogo Matoba
- Applicant: CHILDREN'S MEDICAL CENTER CORPORATION
- Applicant Address: US MA Boston
- Assignee: CHILDREN'S MEDICAL CENTER CORPORATION
- Current Assignee: CHILDREN'S MEDICAL CENTER CORPORATION
- Current Assignee Address: US MA Boston
- Agency: Greenberg Traurig, LLP
- Agent Melissa Hunter-Ensor; Wade Haaland
- Main IPC: C12N5/073
- IPC: C12N5/073 ; A01K67/027 ; C12N15/113 ; C12N15/877 ; C12N5/0735

Abstract:
The present invention provides methods and compostions to improve the efficiency of somatic cell nuclear transfer (SCNT) and the consequent production of nuclear transfer ESC (ntESC) and transgenic cells and/or non-human animals. More specifically, the present invention relates to the discovery that trimethylation of Histone H3-Lysine 9 (H3K9me3) in reprogramming resistant regions (RRRs) in the nuclear genetic material of donor somatic cells prevents efficient somatic cell nuclear reprogramming or SCNT. The present invention provide methods and compositions to decrease H3K9me3 in methods to improve efficacy of SCNT by exogenous or overexpression of the demethylase Kdm4 family and/or inhibiting methylation of H3K9me3 by inhibiting the histone methyltransferases Suv39h1 and/or Suv39h2.
Public/Granted literature
Information query